Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces the FDA clearance of the pocket-sized PICO◊ system, a single use Negative Pressure Wound Therapy (NPWT) system. PICO is cleared for use both in a hospital and homecare setting and expands the use of NPWT from the traditional wound care population to include a wider range of patients undergoing orthopaedic surgery, plastic surgery and general surgical procedures. This FDA clearance follows the recent successful launch of PICO in Europe, Canada, and Australia.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51011-smith-nephew-pico-system-fda-approval-npwt
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for the BD Veritor™ System for rapid detection of Flu A+B. This is the first rapid influenza test system that incorporates a digital read out of results to receive CLIA waiver.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53615-bd-veritor-system-influenza-test-receives-510k-clearance-fda-clia-waiver
Based on its recent analysis of the nuclear cardiology market, Frost & Sullivan recognizes Siemens Healthcare with the 2011 North America Frost & Sullivan Product Differentiation Excellence of the Year Award for its IQ-SPECT, a distinct imaging solution. This product not only offers high-quality imaging by achieving maximum counts, but does so in the quarter amount of time taken by conventional single photon emission computed tomography (SPECT) systems and with less radiation.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/frostsullivan/53611/
Marketing systems will help your business so much that if you don’t have a marketing system then your really in need of this post today.
http://themikesherratt.com/marketing-system-perfect-marketing-system/
A Forbes magazine headline said this week, “Innovation Saves the World.” But can innovation save the world’s broken healthcare system? This question will be before hundreds of chief executive officers, partners and top executives from many of the world’s largest and most progressive companies and investor groups when they meet in San Francisco for the 2nd Annual Global Leaders Healthcare Forum on January 10, 2012.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53568-the-global-leaders-healthcare-forum-san-francisco-2011
Prem Rabindranauth, MD, a heart surgeon at Gundersen Lutheran Health System in La Crosse, Wis., is using an exciting technique, called minimally invasive coronary surgery (MICS), to perform heart bypass surgery. To perform MICS, a very small three-inch cut is made between the ribs instead of the long cut through the breast bone that is needed with traditional open heart surgery. This means less pain and blood loss, fewer risks for problems, shorter hospital stays and quicker healing time.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/gundluth/49124/
CareFusion today launched the Pyxis® Enterprise System (ES) platform, a new generation of its industry-leading automated dispensing systems that will enable hospital customers to simplify and standardize the medication management process, both within a single facility and across an entire health system.
The new CareFusion Pyxis hardware and software brings key benefits to pharmacy, nursing and information technology (IT) departments.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53365-carefusion-unveils-pyxis-automated-medication-dispensing-system
Boston Scientific Corporation (NYSE:BSX) announces U.S. Food and Drug Administration (FDA) approval for the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System, the Company’s next-generation drug-eluting stent (DES) technology. The PROMUS Element Stent, designed to provide physicians improved DES performance in treating patients with coronary artery disease, is built on an innovative platinum chromium (PtCr) platform with the market-leading everolimus drug. The Company plans to begin marketing the product in the U.S. immediately.
To view Multimedia News Release, go to http://www.multivu.com/mnr/43510-boston-scientific-fda-promus-element-plus-platinum-chromium-stent-system
The Medium Extended Air Defense System (MEADS) successfully completed its first flight test today at White Sands Missile Range, N.M.
The PAC-3 Missile Segment Enhancement (MSE) MEADS Certified Missile Round was employed during the test along with the MEADS lightweight launcher and battle manager.
The test demonstrated an unprecedented over-the-shoulder launch of the MSE missile against a simulated target attacking from behind. It required a unique sideways maneuver, demonstrating a 360-degree capability. The missile executed a planned self-destruct sequence at the end of the mission after successfully engaging the simulated threat.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53248-meads-conducts-successful-first-flight-test-white-sands-missile-range
